Effect of intravenous magnesium sulphate for intraoperative anaesthetic requirements for patients under monitored anesthesia care during hysteroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023497

Enrollment

Unknown

Registered

2019-05-31

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial disorders

Interventions

control group:None

experimental group :magnesium sulphate

Eligibility

Sex/Gender

Female

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 55 years, ASA class?-?, patients scheduled for elective hysteroscopy.

Exclusion criteria

Exclusion criteria: Patients with uncontrolled hypertension, cardiac dysfunction (ejection fraction 150 µmol/l), preoperative opioids use, neurological disorder, diabetes, morbid obesity (body mass index > 30), history of chronic pain, drugs or alcohol abuse.

Design outcomes

Primary

Measure	Time frame
Propofol and fentanyl requirements;	—

Secondary

Measure	Time frame
Respiratory depression;Postoperative pain;POVN;	—

Countries

China

Contacts

Public ContactJingyan Lin

North Sichuan Medical College

419931094@qq.com+86 15983771119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026